Luke Bergerud

Luke Bergerud has extensive work experience in the biotechnology industry. Luke started their career at Human Genome Sciences as a Research Associate and later became a Project Coordinator. Luke then joined GlaxoSmithKline as a Senior Project Coordinator, where they managed multiple programs and ensured alignment across departments. After that, Luke worked at AstraZeneca as a Scientist I, leading analytical projects and supporting biologic production. Currently, they are working at REGENXBIO Inc. as a Director (Global Project Management), responsible for project management and driving cross-functional alignment for ocular AAV gene therapy programs. Prior to this role, they held positions as an Associate Director (Global Project Management) and a Senior Manager (Manufacturing Sciences) at REGENXBIO Inc., leading AAV gene therapy programs through IND filing and clinical studies.

Luke Bergerud obtained a Masters degree in Biotechnology from The Johns Hopkins University, which they attended from 2004 to 2006. Prior to that, they received a Bachelor of Science degree in Molecular Biology from the University of Wisconsin-Madison, where they studied from 1999 to 2003. Additionally, Luke has obtained a certification in Artificial Intelligence in Pharma and Biotech from the MIT Sloan School of Management, though the specific month and year of completion are not provided.